Observational studyInvestigative and clinical urology2023

A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.

Seung-Hwan Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.